Exploratory analysis of immunomodulatory factors identifies L1CAM as a prognostic marker in alveolar soft-part sarcoma.
Mondaza-Hernandez JL, Hindi N, Fernandez-Serra A, Ramos R, Gonzalez-Cámpora R, Gómez-Mateo MC, Martinez-Trufero J, Lavernia J, Lopez-Pousa A, Laínez N, Martinez-Garcia J, Valverde C, Vaz-Salgado MÁ, Garcia-Plaza G, Marin-Borrero I, Carrillo-Garcia J, Martin-Ruiz M, Romero P, Gutierrez A, López-Guerrero JA, Moura DS, Martin-Broto J.
Mondaza-Hernandez JL, et al. Among authors: romero p.
Ther Adv Med Oncol. 2024 Nov 4;16:17588359241293951. doi: 10.1177/17588359241293951. eCollection 2024.
Ther Adv Med Oncol. 2024.
PMID: 39502403
Free PMC article.